Can I use Ideenat 150mg tablet with other combination of treatment?

Ideenat 150mg tablet can be used alongside with other treatments for several types of blood cancer but only under the supervision of a healthcare professional.

Is Ideenat 150mg tablet completely cure blood cancer?

Ideenat 150mg tablet stop the growth of cancer in the body and give patient relief but it does not offer a permanent cure and must be taken as a long term treatment plan under medical supervision.

What are the side effects of Ideenat 150mg tablet?

The common side effects of Ideenat 150mg tablet are ulcer, skin rashes, diarrhea, liver damage, infections, breathlessness, weakness etc.

Buy Ideenat 150mg Tablet Online: Price, 21% Discount, Uses, and Side Effects

Name: Ideenat 150mg Tablet
Brand: Ideenat
Price: 14100 INR
Availability: InStock
Rating: 4.33 (6 reviews)

Description

Ideenat 150mg tablet is an anti-cancer medication prescribed by healthcare professional. It is used in the treatment of several types of cancer such as chronic lymphocytic leukemia (CLL), follicular lymphoma (FL) and small lymphocytic lymphoma (SLL).

Its active ingredient is Idelalisib which belongs to the drug class of PI3K (Phosphoinositide 3-kinase) inhibitors. The medicine acts as an antinoplastic (anti-cancer) agent.

The medicine works by blocking PI3K enzyme, disrupting cancer cell growth and survival pathways. The medication should be recommended to adult children under the age of 18.

Follow the recommended dosage as administered by the healthcare professional.

Uses

Chronic lymphocytic leukemia (CLL),
Follicular lymphoma (FL)
Small lymphocytic lymphoma (SLL)

Side Effects

Ideenat 150mg tablet can cause serious side effects some are mild and some are severe. Patients may experience symptoms, however many of them are treated on their own and some need proper medical attention. Common ones include:

Skin-peeling Mouth ulcer
Ulcer in throat, nose, genital, and eye
Skin rashes
Fever
DRESS syndrome (enlarged lymph nodes)
Infections
Liver damage
Change in the number of WBC
Increased liver enzymes
Lung inflammation
Reddish patch
Changes in the skin color

How To Use

Ideenat 150mg tablet should be taken under doctor prescription.
The tablet should be taken with or without food at the same time everyday.
Never skip or stop the medication without consultation with a doctor.
Regular follow ups and proper medical supervision attention are essential to ensure safe and effective treatment.

How It Works

Ideenat 150mg tablet, a selective PI3K- delta inhibitor. It blocks signaling pathways responsible for the growth and survival of malignant B cells.

This inhibition leads to reduced cell proliferation and induces programmed cell death. As, a result it helps control the cell progression of certain blood cancers like CLL and lymphomas.

Safety Advice

Alcohol

Taking Ideenat 150mg tablet with alcohol may be dangerous to the patient's health but consult the doctor before taking the medication.

Pregnancy

Ideenat 150mg tablet is not recommended to pregnant and breastfeeding women as it may affect the fetus or newborn. Take guidance from a healthcare expert to ensure safety and precautions.

Breast Feeding

Breastfeeding women should not be advisable for taking Ideenat 150mg tablet as the medicine is passed through breast that somehow affect breast milk. Discuss with the doctor for more query.

Driving

Ideenat 150mg tablet may not cause dizziness or sleepiness but patient may still experience some side effects. It is important to monitor the response of medication and report any unusual symptoms to the doctor.

Kidney

Kidney patients should take precautions while using Ideenat 150mg tablet as dose adjustment and doctor's prescription is much needed.

Liver

Ideenat 150mg tablet is unsafe for liver patients as this may cause common as well as severe side effects. Consult the healthcare supervision for proper medical attention.

FAQs

Ideenat 150mg tablet should be taken once a day.

Consult the doctor about the proper dosage and duration.

References

Gopal, A. K., Kahl, B. S., Flowers, C. R., Martin, P., Ansell, S. M., Abella-Dominicis, E., ... & Friedberg, J. W. (2017). Idelalisib is effective in patients with high-risk follicular lymphoma and early relapse after initial chemoimmunotherapy. Blood, The Journal of the American Society of Hematology, 129(22), 3037-3039. https://pubmed.ncbi.nlm.nih.gov/28325864/
Weidner, A. S., Panarelli, N. C., Geyer, J. T., Bhavsar, E. B., Furman, R. R., Leonard, J. P., ... & Yantiss, R. K. (2015). Idelalisib-associated colitis: histologic findings in 14 patients. The American journal of surgical pathology, 39(12), 1661-1667. https://pubmed.ncbi.nlm.nih.gov/26448188/
Gopal, A. K., Kahl, B. S., De Vos, S., Wagner-Johnston, N. D., Schuster, S. J., Jurczak, W. J., ... & Salles, G. A. (2014). PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma. New England Journal of Medicine, 370(11), 1008-1018. https://pubmed.ncbi.nlm.nih.gov/24450858/
Brown, J. R., Byrd, J. C., Coutre, S. E., Benson, D. M., Flinn, I. W., Wagner-Johnston, N. D., ... & Furman, R. R. (2014). Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia. Blood, The Journal of the American Society of Hematology, 123(22), 3390-3397. https://pubmed.ncbi.nlm.nih.gov/24615777/
Coutré, S. E., Barrientos, J. C., Brown, J. R., de Vos, S., Furman, R. R., Keating, M. J., ... & Zelenetz, A. D. (2015). Management of adverse events associated with idelalisib treatment: expert panel opinion. Leukemia & lymphoma, 56(10), 2779-2786. https://pubmed.ncbi.nlm.nih.gov/25726955/

Ideenat 150mg Tablet

About The Product